Giant cell arteritis: Diagnosis and treatment
作者： J.M. Calvo Romero
DOI: 10.1016/J.RCENG.2015.05.001
关键词:
摘要: Giant cell arteritis is the most common primary systemic vasculitis in adults. The condition granulomatous of large and medium vessels, which occurs almost exclusively patients aged 50 years or more. This article reviews diagnosis treatment disease.
revclinesp.es参考文章(74)
C Garcia-Porrua, J Llorca, M A Gonzalez-Gay, A Piñeiro, R Pego-Reigosa, T Dierssen, Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clinical and Experimental Rheumatology. ,vol. 22, ,(2004)
Michael Schirmer, Jörg Henes, Wolfgang L Gross, Ina Kötter, Torsten Witte, Peter Lamprecht, Jan Loock, Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centres. Clinical and Experimental Rheumatology. ,vol. 30, ,(2012)
G S Breuer, R Nesher, G Nesher, Effect of biopsy length on the rate of positive temporal artery biopsies. Clinical and Experimental Rheumatology. ,vol. 27, ,(2009)
C. Sudlow, R. Finlay, A. G Freeman, P. Roome, P. Hodgkins, R. Hull, Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Urgency in giving steroids in giant cell arteritis is still not widely appreciated. BMJ. ,vol. 315, pp. 549- 549 ,(1997) , 10.1136/BMJ.315.7107.549
Letellier P, Duhamel E, El Kouri D, Dupond Jl, Pottier Ma, Hamidou M, Jego P, Capdeville J, Grosbois B, Planchon B, Le Strat A, De Wazieres B, Connan L, Chevalet P, Agron L, Dien G, Pottier P, Barrier Jh, Magadur-Joly G, A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. The Journal of Rheumatology. ,vol. 27, pp. 1484- ,(2000)
Gene G Hunder, Carlo Salvarani, Nicolò Pipitone, Francesco Muratore, Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis. Clinical and Experimental Rheumatology. ,vol. 31, pp. 86- 92 ,(2013)
Calvo-Río, Ortego-Centeno N, Herrero-Beaumont G, Rueda-Gotor J, Loricera J, Ortiz-Sanjuán F, Pina T, Aurrecoechea E, Lluch P, Palmou-Fontana N, Freire M, Moll C, Castañeda S, Narváez J, Blanco R, Bravo B, Rubio E, Mínguez M, Peiró E, Melchor S, Calvo-Alén J, González-Vela C, González-Gay Má, Humbría A, Mata C, Tocilizumab in refractory aortitis: study on 16 patients and literature review. Clinical and Experimental Rheumatology. ,vol. 32, ,(2014)
Grant T. Liu, Joel S. Glaser, Norman J. Schatz, J. Lawton Smith, Visual Morbidity in Giant Cell Arteritis. Clinical Characteristics and Prognosis for Vision Ophthalmology. ,vol. 101, pp. 1779- 1785 ,(1994) , 10.1016/S0161-6420(94)31102-X
V. Rodriguez-Valverde, R. Blanco, M. Figueroa, V. M. Martínez-Taboada, J. Armona, E. Uriarte, M. A. Gonzalez-Gay, Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clinical Rheumatology. ,vol. 19, pp. 73- 75 ,(2000) , 10.1007/S100670050017
Corey W. Waldman, Steven D. Waldman, Reid A. Waldman, Giant cell arteritis. Medical Clinics of North America. ,vol. 97, pp. 329- 335 ,(2013) , 10.1016/J.MCNA.2012.12.006